Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cardinal Distribution acquiring Solomons Co.

Executive Summary

Wholesale drug distributors announce agreement that calls for Cardinal to acquire all of Solomons stock in exchange for 849,364 Cardinal common shares, worth $23.5 mil. based on the stock price on March 11. Cardinal has 22.7 mil. shares fully diluted. The acquisition is expected to be completed by mid-April. Solomons' existing management will remain and the company will continue to operate as an independent entity. Savannah, Ga.-based Solomons serves Georgia, Florida, South Carolina and sections of adjoining states from its 98,000 square foot facility. Solomons has annualized revenues of about $180 mil.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS022279

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel